News Items

News Items

Share this post

News Items
News Items
Welcome News.
Copy link
Facebook
Email
Notes
More

Welcome News.

Life from lifelessness.

John Ellis
Sep 29, 2021
∙ Paid
3

Share this post

News Items
News Items
Welcome News.
Copy link
Facebook
Email
Notes
More
Share

Give a gift subscription

1. With two dozen COVID-19 vaccines already in use around the world, a successful efficacy trial of yet another candidate might elicit yawns. But the findings announced by China’s Clover Biopharmaceuticals on 22 September—in a press release and a slide deck full of unusually fine-grained information—stood out. Two doses of Clover’s vaccine, based on a m…

Keep reading with a 7-day free trial

Subscribe to News Items to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 John Ellis
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More